ESC Premium Access

Differences in VWF activity in von willebrand disease type 2A patients versus LVAD patients with the acquired von willebrand syndrome.

Congress Presentation

About the speaker

Doctor Marc Vanderheyden

Olv Hospital Aalst, Aalst (Belgium)
0 follower

6 more presentations in this session

Expression levels of cTnTs and TnI were modified in the heart of pediatric and adults heart failure (HF) patients after ventricular assist device (VAD) implant

Speaker: Doctor C. Caselli (Pisa, IT)


Disparities in decisional regret among left ventricular assist device patient and caregiver recipients

Speaker: Doctor E. Stahl (Atlanta, US)


Changes in plasma neprilysin levels after left ventricular assist device implantation and association with short-term outcomes

Speaker: Doctor E. Yuce (Izmir, TR)


Pre-operative liver dysfunction is associated with higher mortality rates at 1-year after left ventricular assist device implantation.

Speaker: Mr R. Muslem (Rotterdam, NL)


Invasive exercise haemodynamics predict functional capacity in patients with advanced heart failure implanted with a left ventricular assist device

Speaker: Doctor A. Koshy (Leeds, GB)


Access the full session

Predictors of outcome after LVAD implantation

Speakers: Doctor M. Vanderheyden, Doctor C. Caselli, Doctor E. Stahl, Doctor E. Yuce, Mr R. Muslem...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by